Sezgin Mine, Ekizoğlu Esme, Yeşilot Nilufer, Çoban Oğuzhan
Istanbul University Istanbul Faculty of Medicine, Deparment of Neurology, Istanbul, Türkiye.
Noro Psikiyatr Ars. 2024 Nov 30;61(4):345-350. doi: 10.29399/npa.28642. eCollection 2024.
A severe infection such as COVID-19 may trigger a stroke. The imaging and clinical features of patients with COVID-19 are not well-defined. We aimed to analyze neuroimaging and clinical features of stroke patients with COVID-19.
The demographic and clinical data of 21 stroke cases with confirmed COVID-19 (StrokeCov) between April 2020-May 2021 were collected prospectively. An experienced stroke neurologist evaluated neuroimaging findings. A control group of gender, age, and risk factors adjusted 104 stroke patients were included.
Mean age was 66.3 (±13.3) and 66.2 (±13) years in the StrokeCov group and control group (CG), with similar male-to-female ratios (85%) and without significant difference regarding diabetes, hypertension, hyperlipidemia, and atrial fibrillation between groups (p>0.05). Infarcts were most frequently seen in the territory of middle cerebral artery (8 patients; 40%), followed by multiple arterial territories (6 patients; 30%). Ischemic lesions were more frequently localized in both anterior and posterior vascular systems in StrokeCov group (3 patients; 15%) in comparison to CG (2 patients; 2%; p=0.02). Although, hemorrhagic transformation was observed more frequently in StrokeCov group (6 patients; 30%) than CG (11 patients; 10%; p=0.02); statistically significant difference was not seen in terms of acute and preventive treatments given to both groups. The mRS scores on discharge were worse in the StrokeCov group (p<0.00).
Ischemic stroke lesions in StrokeCov group are more likely to be localized on multiple arterial territories and develop hemorrhagic transformation. Poor clinical outcome and in-hospital death are more common in stroke due to COVID-19.
诸如新型冠状病毒肺炎(COVID-19)这样的严重感染可能引发中风。COVID-19患者的影像学和临床特征尚不明确。我们旨在分析COVID-19中风患者的神经影像学和临床特征。
前瞻性收集了2020年4月至2021年5月期间确诊为COVID-19的21例中风病例(StrokeCov)的人口统计学和临床数据。一位经验丰富的中风神经科医生评估神经影像学检查结果。纳入了一个在性别、年龄和风险因素方面进行了调整的104例中风患者作为对照组。
StrokeCov组和对照组(CG)的平均年龄分别为66.3(±13.3)岁和66.2(±13)岁,男女比例相似(85%),两组在糖尿病、高血压、高脂血症和心房颤动方面无显著差异(p>0.05)。梗死最常见于大脑中动脉区域(8例患者;40%),其次是多个动脉区域(6例患者;30%)。与CG组(2例患者;2%;p=0.02)相比,StrokeCov组缺血性病变在前、后血管系统均更常见(3例患者;15%)。虽然StrokeCov组出血性转化的发生率高于CG组(6例患者;30%比11例患者;10%;p=0.02);但两组在急性和预防性治疗方面未见统计学显著差异。StrokeCov组出院时的改良Rankin量表(mRS)评分更差(p<0.00)。
StrokeCov组的缺血性中风病变更可能位于多个动脉区域并发生出血性转化。COVID-19所致中风的临床预后较差和院内死亡更为常见。